We are live on !
Find out more
BlackRock Advisors Portfolio holdings
AUM
$98.8B
Turnover
6.58%
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$106B
AUM Growth
+$3.62B
(+3.5%)
Cap. Flow
-$3.94B
Cap. Flow % of AUM
Cap. Flow %
-3.73%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
3,812
New
177
Increased
783
Reduced
2,146
Closed
145
Avg Time Held
Equity + Options
0.9
years
Top 10 Avg Time Held
Equity + Options
0.7
years
Top 20 Avg Time Held
Equity + Options
0.7
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.8
years
Top 20 Avg Time Held Equity only
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$743M |
| 2 |
Anadarko Petroleum
APC
|
+$215M |
| 3 |
Chevron
CVX
|
+$189M |
| 4 |
XEC
CIMAREX ENERGY CO
XEC
|
+$161M |
| 5 |
Meta Platforms (Facebook)
META
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$281M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$219M |
| 4 |
Eli Lilly
LLY
|
+$212M |
| 5 |
RTX Corp
RTX
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.65% |
| 2 | Healthcare | 15.4% |
| 3 | Energy | 11.63% |
| 4 | Industrials | 11.49% |
| 5 | Miscellaneous | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AET
101
DELISTED
Aetna Inc
AET
| $266M | 0.25% |
3,286,193
-756,588
| -19% | -$57.3M |
2013 Q2
4 quarters
|
|
102
HCA Healthcare
HCA
$99.3B
| $266M | 0.25% |
4,721,192
-50,311
| -1% | -$2.65M |
2013 Q2
4 quarters
|
|
103
Regeneron Pharmaceuticals
REGN
$81.4B
| $264M | 0.25% |
935,337
+356,403
| +62% | +$106M |
2013 Q2
4 quarters
|
|
104
CVS Health
CVS
$118B
| $264M | 0.25% |
3,503,601
-105,384
| -3% | -$7.96M |
2013 Q2
4 quarters
|
|
|
XEC
105
DELISTED
CIMAREX ENERGY CO
XEC
| $263M | 0.25% |
1,834,329
+1,263,577
| +221% | +$161M |
2013 Q2
4 quarters
|
|
106
Kimberly-Clark
KMB
$35.1B
| $259M | 0.24% |
2,425,475
-160,462
| -6% | -$17.1M |
2013 Q2
4 quarters
|
|
|
CELG
107
DELISTED
Celgene Corp
CELG
| $258M | 0.24% |
3,001,896
-84,488
| -3% | -$6.43M |
2013 Q2
4 quarters
|
|
108
Lockheed Martin
LMT
$127B
| $258M | 0.24% |
1,603,356
-42
| -0% | -$6.83K |
2013 Q2
4 quarters
|
|
109
Berkshire Hathaway Class B
BRK.B
$1.14T
| $252M | 0.24% |
1,989,760
+405,647
| +26% | +$51.3M |
2013 Q2
4 quarters
|
|
110
Quest Diagnostics
DGX
$25.9B
| $249M | 0.24% |
4,250,242
+585,940
| +16% | +$34.3M |
2013 Q2
4 quarters
|
|
111
Thermo Fisher Scientific
TMO
$255B
| $246M | 0.23% |
2,081,768
-83,937
| -4% | -$9.9M |
2013 Q2
4 quarters
|
|
|
KRFT
112
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $245M | 0.23% |
4,093,226
+132,441
| +3% | +$7.66M |
2013 Q2
4 quarters
|
|
113
SPDR Gold Trust
GLD
$141B
| $242M | 0.23% |
1,887,450
-628,450
| -25% | -$78.1M |
2013 Q2
4 quarters
|
|
114
General Mills
GIS
$17.7B
| $241M | 0.23% |
4,577,573
-88
| -0% | -$4.69K |
2013 Q2
4 quarters
|
|
115
APA Corp
APA
$17.2B
| $239M | 0.23% |
2,379,101
+477,613
| +25% | +$43.3M |
2013 Q2
4 quarters
|
|
116
American Tower
AMT
$86.3B
| $237M | 0.22% |
2,629,174
-262,339
| -9% | -$22.7M |
2013 Q2
4 quarters
|
|
|
TFCFA
117
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $236M | 0.22% |
6,700,197
+951,046
| +17% | +$32.3M |
2013 Q3
3 quarters
|
|
118
CME Group
CME
$106B
| $228M | 0.22% |
3,216,019
+4
| +0% | +$282 |
2013 Q2
4 quarters
|
|
|
GG
119
DELISTED
Goldcorp Inc
GG
| $228M | 0.22% |
8,175,043
-280,696
| -3% | -$6.97M |
2013 Q2
4 quarters
|
|
|
ALXN
120
DELISTED
Alexion Pharmaceuticals
ALXN
| $220M | 0.21% |
1,404,849
+238,442
| +20% | +$37.6M |
2013 Q2
4 quarters
|
|
121
Bausch Health
BHC
$2.36B
| $219M | 0.21% |
1,737,877
-153,785
| -8% | -$19.6M |
2013 Q2
4 quarters
|
|
122
Bread Financial
BFH
$3.94B
| $209M | 0.2% |
929,008
-87,115
| -9% | -$17.7M |
2013 Q2
4 quarters
|
|
123
abrdn Physical Gold Shares ETF
SGOL
$6.96B
| $206M | 0.19% |
15,786,380
-261,250
| -2% | -$3.31M |
2013 Q2
4 quarters
|
|
124
AES
AES
$10.7B
| $206M | 0.19% |
13,236,068
-2,357,802
| -15% | -$33.9M |
2013 Q2
4 quarters
|
|
125
Goldman Sachs
GS
$257B
| $206M | 0.19% |
1,227,965
-101,346
| -8% | -$16.4M |
2013 Q2
4 quarters
|
|
Similar funds
BlackRock Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, BlackRock Advisors held 3,812 positions worth $106B, up 3.5% from $102B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock Advisors withdrew a net $3.94B in Q2 2014, closing 145 positions and reducing 2,146 holdings. Its most notable exit was PPL CORP CORP UITS CONSISTING OF PUR CONTRACT JR SUB NTS, an estimated $40.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Energy.
Against the trend, BlackRock Advisors opened a new position in iShares US Financials ETF worth $130M.
- BlackRock Advisors's largest Q2 2014 buy was iShares US Financials ETF: 3,120,594 shares worth $130M.
- BlackRock Advisors added most to Apple in Q2 2014, an estimated $743M increase.
- BlackRock Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $281M.
- BlackRock Advisors fully exited PPL CORP CORP UITS CONSISTING OF PUR CONTRACT JR SUB NTS in Q2 2014, selling an estimated $40.9M.
- BlackRock Advisors's ten largest holdings make up 14% of its $106B portfolio in Q2 2014.
- BlackRock Advisors opened 177 new positions and closed 145 in Q2 2014.
- BlackRock Advisors's portfolio value rose 3.5% quarter-over-quarter to $106B.
Based on BlackRock Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.